Koroa-birusak eragindako heriotzen % 67 Adinekoen Egoitzetan suertatu da. Euskadin 367 Egoitza dago eta bertan 13.899 lagun bizi dira.
Dakigunez gure egoitza asko eta asko Foru-Aldundiek eta Euskal Udalek joan den mendeko 80ko eta 90eko hamarkadetan sortutakoak dira. Bere diseinuak egoiliar taldeka hartzea arbatzatzat izan du eta, ondorioz, talde-gune ugari daukate: jangela, egon gela, telebista gela, taberna eta abar taldeak hartzera zuzenduta daude.
JAKIBERRI Proiektua azkar prestatzeko euskal janari naturala, osasungarria, anitza eta nutritiboa izango den Euskal Janari Lasterra lortzeko I+G+b-ko proiektua da (Euskal Janari Lasterra, "Healthy Basque Fast Food").
JAKIBERRI proiektua honako hauek bultzatzen dute: ISEA, Basque Culinary Center, Mondragon Health, Jakion, Auzo Lagun eta Debagoieneko Garapen Agentzia, Innobasquen laguntza dutelarik.
Gipuzkoako Foru Aldundiak JAKIBERRI Proiektua babesten du “Etorkizuna Eraikiz GipuzkoaLab” ekimenaren bitartez.
Anil Duggal has always had a knack for invention — the GE Global Research chief scientist has 98 U.S. patents to his name. Now, with the support of his colleagues Jeff Ashe and Azar Alizadeh, Duggal is on the verge of turning years of abandoned research into what might be the world’s most advanced skin-surface medical sensors.
Europeans suffer from the highest bad cholesterol in the world, with a prevalence of 54% for both sexes, according to the World Health Organisation (WHO). However, the chronic disease continues to be neglected by policymakers, in favour of other long-term illnesse.
According to a 2011 report by the Cardiovascular Resource Group, 133.3 million people in the five biggest EU countries (Germany, France, Italy, Spain and the UK) suffer from too much bad cholesterol, comparable to the overall number in the United States (135.1 million). Statistics in the report show that the numbers have grown steadily over the past years.
HealthTech and Digital Health investment doubled in 2013 to over $2 billion. That’s enough to prove that the healthcare revolution of the century is definitely here bringing massive changes that are affecting healthcare providers and payers alike. You just have to look at the transition from fee for services to value-based healthcare delivery services to know we’ve arrived at the age of Retail Medicine with the growing empowerment of patients.
For device makers and drug companies, going through the process of clinical trials for new treatments is expensive and time consuming. But they have to do it to get FDA approval.
Part of the problem is a data problem. Biosciences companies need a virtual hub where all the clinical information lives, and where it can be accessed and collaborated on.
MedCity News writes about all kinds of startups whether their pitch is more at home on CNN or MIT’s Technology Review. We are always so focused on what’s coming next that we forget to reflect on all the companies we have recently discovered. To solve this, we’ve created a monthly report to make sure none of our readers missed any of these posts.
